WEBSITECHANGES

Website Changes

---

02/02/2024

Australian government steps in to fund experimental brain cancer drug

---

02/02/2024

TME Pharma Announces Final Median Overall Survival Data Reaching 19.9 Months for NOX-A12 Combination Regimen in GLORIA Brain Cancer Trial and Survival Rate 10-Fold Greater Than Standard of Care

---

02/02/2024

Biomarker Testing for Brain Cancer!

---

02/02/2024

Press Release IB awarded a $100,000 grant by the Musella Foundation

---

02/01/2024

Musella Foundation`s Copayment Assistance Program Reaches a Monumental Milestone!

---

01/29/2024

Conditional Approval for Human Drugs

---

01/29/2024

Plus Therapeutics Releases a New ReSPECT-GBM Clinical Trial Guide for Recurrent Glioblastoma Patients

---

01/28/2024

Blood test could diagnose patients with deadly brain tumors, including glioblastoma

---

01/28/2024

Surgical site infections after glioblastoma surgery: boon or bane?

---

01/28/2024

Adjuvant convection-enhanced delivery for the treatment of brain tumors

---

01/28/2024

Statement From Chimerix on Onc-201 Expanded Access

---

01/25/2024

The role of GammaTile in the treatment of brain tumors: a technical and clinical overview

---

01/24/2024

Duke Increases Equitable Access to Pediatric Brain Tumor Care

---

01/21/2024

Glioblastoma evolution and heterogeneity from a 3D whole-tumor perspective

---

01/16/2024

dCas9/CRISPR-based methylation of O-6-methylguanine-DNA methyltransferase enhances chemosensitivity to temozolomide in malignant glioma

---

01/16/2024

A biologically effective dose comparison between radiosurgery and collagen tile brachytherapy for post-operative treatment of a brain metastasis resection cavity

---

01/15/2024

The safety and accuracy of intratumoral catheter placement to infuse viral immunotherapies in children with malignant brain tumors: a multi-institutional study

---

01/15/2024

Potent in vivo efficacy of oral gallium maltolate in treatment-resistant glioblastoma

---

01/15/2024

Musella Foundation awards first grant of 2024!

---

01/12/2024

Research shows deadly brain cancer can mimic healthy neurons

---

01/11/2024

Brain Cancer Lab webinar: Navigating Brain Cancer

---

01/07/2024

Network targeting combination therapy of synthetic lethal vulnerabilities in 9p21-deficient glioblastoma: A case report

---

01/06/2024

Quick survey on clinical trials!

---

01/04/2024

Rigel Announces Collaboration with CONNECT to Conduct a Phase 2 Trial of Olutasidenib in Glioma

---

12/31/2023

2023 Year In Review: Major Progress in Brain Tumor Research and Treatment

---